Breast cancer

An in-depth report on the causes, diagnosis, treatment, and prevention of breast cancer.

I Would Like to Learn About:

Related Reports

Menopause

References

American Cancer Society. American Cancer Society Recommendations for Early Breast Cancer Detection in Women Without Breast Symptoms. www.cancer.org/cancer/breast-cancer/screening-tests-and-early-detection.html. Updated October 20, 2015. Accessed July 5, 2017.

American College of Obstetricians and Gynecologists (ACOG). ACOG statement on breast cancer screening guidelines. www.acog.org/About-ACOG/News-Room/Statements/2016/ACOG-Statement-on-Breast-Cancer-Screening-Guidelines. Updated 2016. Accessed July 5, 2017.

American College of Obstetricians-Gynecologists. ACOG Practice Bulletin No. 126: Management of gynecologic issues in women with breast cancer. Obstet Gynecol. 2012;119(3):666-682. PMID: 22353976 www.ncbi.nlm.nih.gov/pubmed/22353976.

Antoniou AC, Casadei S, Heikkinen T, et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;371(6):497-506. PMID: 25099575 www.ncbi.nlm.nih.gov/pubmed/25099575.

Bevers TB, Ward JH, Arun BK, et al. Breast Cancer Risk Reduction, Version 2.2015. J Natl Compr Canc Netw. 2015;13(7):880-915. PMID: 26150582 www.ncbi.nlm.nih.gov/pubmed/26150582.

Burstein HJ, Temin S, Anderson H, et al. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update. J Clin Oncol. 2014;32(21):2255-2269. PMID: 24868023 www.ncbi.nlm.nih.gov/pubmed/24868023.

Centers for Disease Control and Prevention (CDC). Vital signs: racial disparities in breast cancer severity - United States, 2005-2009. MMWR Morb Mortal Wkly Rep. 2012;61(45):922-926. PMID: 23151952 www.ncbi.nlm.nih.gov/pubmed/23151952.

Centers for Disease Control and Prevention (CDC). Breast cancer screening guidelines. www.cdc.gov/cancer/breast/pdf/BreastCancerScreeningGuidelines.pdf. Updated April 19, 2016. Accessed July 5, 2017.

Chen WY, Rosner B, Hankinson SE, Colditz GA, Willett WC. Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA. 2011;306(17):1884-1890. PMID: 22045766 www.ncbi.nlm.nih.gov/pubmed/22045766.

Chlebowski RT, Anderson GL, Gass M, et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA. 2010;304(15):1684-1692. PMID: 20959578 www.ncbi.nlm.nih.gov/pubmed/20959578.

Cuzick J, Sestak I, Bonanni B, et al. Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data. Lancet. 2013;381(9880):1827-1834. PMID: 23639488 www.ncbi.nlm.nih.gov/pubmed/23639488.

Daly MB, Pilarski R, Berry M, et al. NCCN Guidelines Insights: genetic/familial high-risk assessment: breast and ovarian, Version 2.2017. J Natl Compr Canc Netw. 2017;15(1):9-20. PMID: 28040716 www.ncbi.nlm.nih.gov/pubmed/28040716.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Davies C, Godwin J, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. 2011;378(9793):771-784. PMID: 21802721 www.ncbi.nlm.nih.gov/pubmed/21802721.

Fong DY, Ho JW, Hui BP, et al. Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ. 2012;344:e70. PMID: 22294757 www.ncbi.nlm.nih.gov/pubmed/22294757.

Giordano SH, Temin S, Kirshner JJ, et al. Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014;32(19):2078-2099. PMID: 24799465 www.ncbi.nlm.nih.gov/pubmed/24799465.

Gradishar WJ, Anderson BO, Balassanian R, et al. NCCN Guidelines Insights: Breast Cancer, Version 1.2017. J Natl Compr Canc Netw. 2017;15(4):433-451. PMID: 28404755 www.ncbi.nlm.nih.gov/pubmed/28404755.

Harris LN, Ismaila N, McShane LM, et al. Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016;34(10):1134-1150. PMID: 26858339 www.ncbi.nlm.nih.gov/pubmed/26858339.

Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14(11):1086-1094. PMID: 24055415 www.ncbi.nlm.nih.gov/pubmed/24055415.

Kushi LH, Doyle C, McCullough M, et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012;62(1):30-67. PMID: 22237782 www.ncbi.nlm.nih.gov/pubmed/22237782.

Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500-2510. PMID: 23715580 www.ncbi.nlm.nih.gov/pubmed/23715580.

Lyman GH, Temin S, Edge SB, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: 2016 American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017;13(3):196-198. PMID: 28118104 www.ncbi.nlm.nih.gov/pubmed/28118104.

Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014;348:g366. PMID: 24519768 www.ncbi.nlm.nih.gov/pubmed/24519768.

Moyer VA. Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2013;159(10):698-708. PMID: 24061412 www.ncbi.nlm.nih.gov/pubmed/24061412.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 2.2017. www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Updated April 6, 2017. Accessed July 5, 2017.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Risk Reduction. Version 1.2017. www.nccn.org/professionals/physician_gls/PDF/breast_risk.pdf. Updated December 16, 2016. Accessed July 5, 2017.

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) Breast Cancer Screening and Diagnosis Version 1.2016. www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdf. Updated July 27, 2016. Accessed July 5, 2017.

Nelson HD, Zakher B, Cantor A, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med. 2012;156(9):635-648. PMID: 22547473 www.ncbi.nlm.nih.gov/pubmed/22547473.

Partridge AH, Rumble RB, Carey LA, et al. Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2014;32(29):3307-3329. PMID: 25185096 www.ncbi.nlm.nih.gov/pubmed/25185096.

Runowicz CD, Leach CR, Henry NL, et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin. 2016;66(1):43-73 PMID: 26641959 www.ncbi.nlm.nih.gov/pubmed/26641959.

Siu AL, US Preventive Services Task Force. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016;164(4):279-296. PMID: 26757170 www.ncbi.nlm.nih.gov/pubmed/26757170.

U.S. Preventive Services Task Force. Screening for Breast Cancer: Recommendation Statement. Am Fam Physician. 2016;93(8):Online. PMID: 27175847 www.ncbi.nlm.nih.gov/pubmed/27175847.

U.S. Preventive Services Task Force. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Am Fam Physician. 2015;91(2):Online. PMID: 25591222 www.ncbi.nlm.nih.gov/pubmed/25591222.

Valle LF, Agarwal S, Bickel KE, Herchek HA, Nalepinski DC, Kapadia NS. Hypofractionated whole breast radiotherapy in breast conservation for early-stage breast cancer: a systematic review and meta-analysis of randomized trials. Breast Cancer Res Treat. 2017;162(3):409-417. PMID: 28160158 www.ncbi.nlm.nih.gov/pubmed/28160158.

Visvanathan K, Hurley P, Bantug E, et al. Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31(23):2942-2962. PMID: 23835710 www.ncbi.nlm.nih.gov/pubmed/23835710.

Wolff AC, Domcheck SM, Davidson NE,Sacchini V, McCormick B. Cancer of the breast. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff's Clinical Oncology. 5th ed. Philadelphia, PA: Elsevier Saunders; 2014:chap 91.

BACK TO TOP

Review Date: 7/11/2017  

Reviewed By: Richard LoCicero, MD, private practice specializing in Hematology and Medical Oncology, Longsteet Cancer Center, Gainesville, GA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation ( www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2017 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

adam.com